本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

511.97
-4.7700-0.92%
盘后511.970.00000.00%19:30 EDT
成交量:14.55万
成交额:7,449.21万
市值:118.04亿
市盈率:-36.01
高:517.00
开:515.89
低:507.18
收:516.74
52周最高:615.00
52周最低:393.61
股本:2,305.55万
流通股本:1,372.50万
量比:0.55
换手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
净资产收益率:-53.31%
总资产收益率:-17.84%
市净率:22.54
市盈率(LYR):-39.84

数据加载中...

2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

重要事件披露

Form 8-K - Current report
2026/06/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/28

重要事件披露

Form 8-K - Current report
2026/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities